• SENSEX 76,440.73
    416.22 (+0.55%)
  • BANKNIFTY 50,827.50
    -737.35 (--1.43%)
  • IndusInd Bank
    700.65 1,576.00(%)
  • ICICI BLR Growth
    1,003.14 1,001.47(%)
  • Bharat Electron
    274.50 204.00(%)
  • Vodafone Idea
    8.33 19.15(%)
  • SRF
    2,939.00 3,074.95(%)
  • SpiceJet
    46.10 79.90(%)
  • Mazagon Dock
    2,601.00 2,929.98(%)
  • ICICI Bank
    1,338.00 1,372.50(%)
  • M & M
    2,660.50 3,276.30(%)
  • Emcure Pharma
    1,095.80 1,577.50(%)
  • Kalyan Jewellers
    495.00 794.60(%)
  • Hind.Aeronautics
    4,151.55 3,045.95(%)
  • Aegis Logistics
    830.35 1,035.70(%)
  • Tata Consumer
    1,073.55 1,247.39(%)
  • Adani Green
    939.70 2,173.65(%)
  • Zomato Ltd
    205.00 304.50(%)
  • Birlasoft Ltd
    393.85 791.95(%)
  • Quadrant Future
    583.50 743.45(%)
  • Zerodha Nifty 1D
    107.86 108.00(%)
  • Nippon ETF Liq.
    999.99 996.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Lincoln Pharmaceuticals Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 12683.0
  • ISIN : INE405C01035
552.20 1 (0.13%)
  • As on 02 Apr 2025 (EOD)

  • Today’s Low

    549.20

  • Today’s High

    563.55

  • Open

    554.55

  • Perv Close

    551.50

  • 52W Low

    499.00

  • 52W High

    979.50

Key Indicators

  • P/E(TTM)

    12.35

  • Mar.Cap (₹Cr.)

    1,106.04

  • Div & Yield %

    0.33

  • Book Value(₹)

    319.16

  • Debt-Equity Ratio

    0.13

  • AGM Date

    01-Apr-2025

  • EPS

    44.62

  • P/E Ratio

    12.35

Financials Ratios

  • Debt-Equity Ratio

    0.00

  • Mar.Cap (₹Cr.)

    1,106.04

  • RONW (%)

    17.04

  • ROCE (%)

    22.35

Score Board

  • Equity (₹ in Cr.)

    20.03

  • BV (₹)

    319.20

  • Sales( ₹ in Cr.)

    580.55

  • NP (in Cr.)

    92.24

  • NP Var(%)

    27.0

  • Div%

    18.0

  • CPS (₹)

    51.40

  • EPS (₹)

    46.10

  • Traded Value (₹ in Lakhs)

    1,103.94

  • 52 Week High

    979.50

  • 52 Week Low

    499.00

  • Price BSE

    551.0

  • Price NSE

    552.00

  • Market Capital( in Cr.)

    1,103.94

  • P/C Ratio

    10.70

  • P/E Ratio

    12.00

  • Price Vs.BV

    46.10

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales Turnover 580.55 510.31 472.08 422.91 376.09 353.04
Excise Duty 566.00 497.51 460.99 408.82 364.39 341.09
Net Sales 580.55 510.31 472.08 422.91 376.09 353.04
Other Income 34.42 22.48 10.00 5.74 12.13 6.58
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 614.97 532.79 482.08 428.65 388.22 359.62
EXPENDITURE :
Raw Materials 566.00 497.51 460.99 408.82 364.39 341.09
Power & Fuel Cost 566.00 497.51 460.99 408.82 364.39 341.09
Employee Cost 102.90 93.16 79.72 63.20 54.90 48.40
Other Manufacturing Expenses 3.24 2.28 2.50 1.58 3.54 2.34
Selling & Administrative Expenses 61.57 55.17 51.33 51.28 49.98 43.52
Miscellaneous Expenses 3.24 2.28 2.50 1.58 3.54 2.34
Less : Pre-operative Expenses Capitalised :
Total Expenditure 492.73 432.34 386.15 344.98 324.17 301.48
Operating Profit 34.59 29.14 24.49 22.89 21.52 21.38
Interest 1.46 2.03 1.45 1.55 1.98 3.84
Gross Profit 122.24 100.46 95.93 83.67 64.05 58.14
Depreciation 10.62 9.17 8.09 7.56 5.47 4.92
Profit Before Tax 122.24 100.46 95.93 83.67 64.05 58.14
Tax 25.21 24.73 24.50 21.25 14.70 14.29
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 3.49 1.59 0.72 0.25 -0.24 -2.78
Reported Net Profit 93.30 72.90 69.35 62.25 49.56 46.64
Extraordinary Items 122.24 100.46 95.93 83.67 64.05 58.14
Adjusted Net Profit 93.30 72.90 69.35 62.25 49.56 46.64
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 0.00 0.00 0.00 0.00 0.00 0.00
Statutory Appropriations 3.61 3.00 3.00 3.00 3.00 3.00
P & L Balance carried down 93.30 72.90 69.35 62.25 49.56 46.64
Dividend - - - - - -
Preference Dividend - - - - - -
Equity Dividend (%) 18.00 15.00 15.00 15.00 15.00 15.00
Dividend Per Share(Rs) 1.80 1.50 1.50 1.50 1.50 1.50
Earnings Per Share-Unit Curr 46.58 36.40 34.63 31.08 24.78 23.32
Book Value 3.61 3.00 3.00 3.00 3.00 3.00
Book Value(Adj)-Unit Curr 3.61 3.00 3.00 3.00 3.00 3.00

Shareholding Pattern

  • Promoter Group

    49.78%

  • Public Share Holding

    50.22%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 8,888,930 44.38 8,888,930 22
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 9,969,930 49.78 9,969,930 25
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 1,033,267 5.16 1,033,267 44
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 362 0.00 362 2
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 1,033,629 5.16 1,033,629 46
2] Non Institution
Bodies Corporate 249,879 1.25 249,879 146
Clearing Members 146 0.00 146 2
Directors of their Relatives 478,400 2.39 478,400 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 424,638 2.12 424,638 623
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 422,980 2.11 422,980 630
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,789,646 8.93 1,789,646 34
Individuals holding nominal share capital up to Rs. 1 lakh 5,563,407 27.78 5,460,883 30,316
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 56,226 0.28 56,226 3
Sub Total 9,026,169 45.06 8,923,645 31,777
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 20,029,728 100.00 19,927,204 31,848

Company Background

Lincoln Pharmaceuticals LtdPharmaceuticals - Indian - Formulations

  • Lincoln Pharmaceuticals Ltd
  • BSE Code : 12683.0
  • ISIN : INE405C01035

  • Incorporation Year

    1995

  • Registered Office

    Lincoln House B/H Satyam Compe
    Science City Road Sola, Ahmedabad,
    Gujarat-380060

  • Telephone

    91-079-67778000

  • FAX

    91-079-67778062

  • Chairman

    Kishorbhai M Shah

  • Managing Director

    Mahendra G Patel

  • Company Secretary

    Trusha Shah

  • Auditor

    Samir M Shah & Associates

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    Link Intime India Pvt Ltd
    5th Floor 506 to 508,
    ABC-I Off C G Road ,Navrangpura
    Mumbai - Ahmedabad-380009

Lincoln Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Lincoln Pharma. 551.15 614.97 580.55 12.35 22.35
Abbott India 30,305.85 6,097.18 5,848.91 48.26 44.71
Astrazeneca Phar 8,518.55 1,330.33 1,295.53 219.61 33.26
P & G Health Ltd 5,152.30 1,166.89 1,151.26 36.15 39.76
Glaxosmi. Pharma 2,793.40 3,530.73 3,407.25 55.55 44.44
Cipla 1,444.55 17,645.00 16,574.34 24.77 20.10
Amrutanjan Healt 642.85 437.58 421.23 37.68 20.84
Fermenta Biotec. 285.30 315.24 307.09 27.04 4.10
Guj. Themis Bio. 271.85 174.19 169.82 56.28 44.82
Bliss GVS Pharma 119.25 638.96 605.46 27.29 11.19
Ambalal Sarabhai 36.15 11.70 3.81 15.45 1.92